Glycosylation: Rising Potential for Prostate Cancer Evaluation
Open Access
Abstract
Prostate cancer is the second most commonly diagnosed cancer among men. Alterations in protein glycosylation are confirmed to be a reliable hallmark of cancer. Prostate-specific antigen is the biomarker that is used most frequently for prostate cancer detection, although its lack of sensitivity and specificity results in many unnecessary biopsies. A wide range of glycosylation alterations in prostate cancer cells, including increased sialylation and fucosylation, can modify protein function and play a crucial role in many important biological processes in cancer, including cell signalling, adhesion, migration, and cellular metabolism. In this review, we summarize studies evaluating the prostate cancer associated glycosylation related alterations in sialylation, mainly α2,3-sialylation, core fucosylation, branched N-glycans, LacdiNAc group and presence of truncated O-glycans (sTn, sT antigen). Finally, we discuss the great potential to make use of glycans as diagnostic and prognostic biomarkers for prostate cancer.Keywords
Funding Information
- Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu (SUB.A070.19.034)
This publication has 145 references indexed in Scilit:
- Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunityMolecular Medicine Reports, 2012
- Loss and Recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation Is a Mechanism Involved in Epithelial-Mesenchymal-Epithelial TransitionsPLOS ONE, 2012
- Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cellsProceedings of the National Academy of Sciences, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Emerging Role of α2,6-Sialic Acid as a Negative Regulator of Galectin Binding and FunctionJournal of Biological Chemistry, 2011
- Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymesJournal of Cell Biology, 2010
- Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell traffickingProceedings of the National Academy of Sciences, 2009
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- Glycomic Characterization of Prostate-Specific Antigen and Prostatic Acid Phosphatase in Prostate Cancer and Benign Disease Seminal Plasma FluidsJournal of Proteome Research, 2009
- Alterations in the Serum Glycome Due to Metastatic Prostate CancerJournal of Proteome Research, 2007